drugset / Trial / NCT00938912
An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy
NaSingle-groupOpen-labelTreatment
Summary
SP848 is an open-label study to evaluate long-term safety, tolerability, and efficacy in children with epilepsy treated with Lacosamide (LCM) oral solution (syrup) or LCM tablets as adjunctive therapy.
Timeline
- Start
- 2009-12-09
- Primary completion
- 2021-05-18
- Completion
- 2021-05-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacosamide | Other / unclassified | 2 mg/kg | Oral |
| Subject | Lacosamide | Other / unclassified | 12 mg/kg | Oral |
| Subject | Lacosamide | Other / unclassified | 100 mg | Oral |
| Subject | Lacosamide | Other / unclassified | 600 mg | Oral |